Skip Navigation
National Institute of Environmental Health SciencesNational Institutes of Health
Increase text size Decrease text size Print this page

B cell depletion in Idiopathic Inflammatory Myopathy

  • Principal Investigator:

    Jo Edwards, Shabina Sultan, David Isenberg, University College, London
  • Study Design:

    Phase 1 open, at University College, London
  • Types & Number of IIM Studied:

    Active Polymyositis or Dermatomyositis (N = 5)
  • Entry Criteria:

    Definite Polymyositis or Dermatomyositis by Bohan and Peter criteria; Refractory to standard therapy
  • IMACS Core Set Measures Included:

    MITAX, Physician and Patient Global Activity Assessment, Manual Muscle Testing (MMT-8), Health Assessment Questionnaire, muscle enzymes; Health Related Quality of Life by SF-36
  • Other Measures Included:

    Myometry, Activities of Daily Living, rash, B cells, serology
  • Primary Outcome:

    Myometry and Creatine kinase
  • Study Duration:

    6 months
  • Funding:

    Myositis Support Group UK
  • Comments:

    Study has completed enrollment

Return to Therapeutic Studies listing

USA.gov Department of Health & Human Services National Institutes of Health
This page URL: http://www.niehs.nih.gov/research/resources/collab/imacs/therapeutic_study5.cfm
NIEHS website: http://www.niehs.nih.gov/
Email the Web Manager at webmanager@niehs.nih.gov
Last Reviewed: October 30, 2007